Text Size

Treatment of M.Graves With Radioactive Iodine: Follow-up Study

The recruitment status of this study is unknown because the information has not been verified recently.
Verified May 2008 by Medisch Centrum Rijnmond-Zuid, Netherlands.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Medisch Centrum Rijnmond-Zuid, Netherlands
ClinicalTrials.gov Identifier:
NCT00525122
First received: September 4, 2007
Last updated: May 21, 2008
Last verified: May 2008
History of Changes
  Purpose

Hypothesis: What is the natural course after treatment with radioactive iodine in patients with hyperthyroidism?

What are the determinants for the development of acute hypo- or hyperthyroidism after treatment with radioactive iodine without antithyroid drugs?


Condition
Hyperthyroidism

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective

Resource links provided by NLM:

Drug Information available for: Iodine Iodide
U.S. FDA Resources

Further study details as provided by Medisch Centrum Rijnmond-Zuid, Netherlands:

Estimated Enrollment: 100
Study Start Date: September 2007
Groups/Cohorts
1
Patients with hyperthyroidism who are will be treated with radioactive iodine.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Patients of 18 years and older with hyperthyroidism who are eligible for treatment with radioactive iodine.

Criteria

Inclusion Criteria:

  • Patients wth hyperthyroidism who are eligible for treatment with radioactive iodine
  • Age > 18 years

Exclusion Criteria:

  • Severe ophthalmopathy
  • Pregnancy or wish to pregnancy on short term
  • Breastfeeding
  • Patients already treated with radioactive iodine
  • Known cardiovascular diseases or other severe comorbidity
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00525122

Contacts
Contact: A. Berghout, MD, PhD 0031 10 2913368 BerghoutA@mcrz.nl

Locations
Netherlands
MCRZ Recruiting
Rotterdam, Zuid-Holland, Netherlands, 3075 EA
Contact: A Berghout, MD, PhD            
Sponsors and Collaborators
Medisch Centrum Rijnmond-Zuid, Netherlands
Investigators
Principal Investigator: A. Berghout, MD, PhD Medisch Centrum Rijnmond-Zuid, Netherlands
Principal Investigator: C. van Noord, MD Medisch Centrum Rijnmond-Zuid, Netherlands
  More Information

No publications provided

Responsible Party: A. Berghout, MCRZ
ClinicalTrials.gov Identifier: NCT00525122     History of Changes
Other Study ID Numbers: 2006/60
Study First Received: September 4, 2007
Last Updated: May 21, 2008
Health Authority: Netherlands: The Central Committee on Research Involving Human Subjects (CCMO)

Keywords provided by Medisch Centrum Rijnmond-Zuid, Netherlands:
hyperthyroidism
radioactive iodine
antithyroid drugs
Hyperthyroidism, treatment with radioactive iodine without antithyroid drugs

Additional relevant MeSH terms:
Hyperthyroidism
Thyroid Diseases
Endocrine System Diseases
Antithyroid Agents
Iodine
Hormone Antagonists
Hormones, Hormone Substitutes, and Hormone Antagonists
Physiological Effects of Drugs
 Pharmacologic Actions
Anti-Infective Agents, Local
Anti-Infective Agents
Therapeutic Uses
Trace Elements
Micronutrients
Growth Substances

ClinicalTrials.gov processed this record on May 16, 2013